Skip to content

Sevoflurane and desflurane concentration for the removal of the ProSeal Laryngeal Mask Airway

Optimal End-Tidal sevoflurane and desflurane concentration for the removal of the ProSeal Laryngeal Mask Airway in Anesthetized Adults

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/12/003250
Enrollment
40
Registered
2012-12-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- cervical carcinoma Health Condition 2: N879- Dysplasia of cervix uteri, unspecified

Interventions

Intervention1: Desflurane concentration for Proseal Laryngeal Mask Airway removal: Anaesthesia will be induced with propofol (2â??3 mg/kg) mixed with lidocaine 0.5 mg.kg). A PLMA will be inserted. Ana

Sponsors

Post Graduate Institute of Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female patients of ASA status 1â??2 and aged 18-60 years, undergoing intracavity implant of caesium for cervical carcinoma under general anaesthesia

Exclusion criteria

Exclusion criteria: Body mass index greater than 35 kg/m2, cervical spine disease, a known difficult airway, mouth opening less than 2.5 cm, upper respiratory tract symptoms in the previous 10 days, or if the patient considered at risk of aspiration (nonfasted, gastrosophageal reflux disease).

Design outcomes

Primary

MeasureTime frame
The ED50 of Sevoflurane and Desflurane for successful PLMA removal.Timepoint: At or one minute after PLMA removal

Secondary

MeasureTime frame
success rate of PLMA removal, emergence time, incidence of coughing, clenching of teeth, complications and manoeuvre used to relieve airway obstruction.Timepoint: At or one minute after PLMA removal

Countries

India

Contacts

Public ContactDr Babita Ghai

Post Graduate Institute of Medical Education and Research, Chandigarh

ghaibabita@hotmail.com9914209533

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026